NewSelf

Our analysis confirms NewSelf’s headline pricing at $199/month for compounded semaglutide and $449/month for compounded tirzepatide—among the more competitive published rates in 2025. The site also emphasizes no membership fees and a single price across dose tiers, an important differentiator versus programs that upcharge as patients titrate. That structure favors patients who escalate to higher maintenance doses.However, the fine print materially affects real‑world cost. Medical weight loss programs carry a three‑month commitment because three months of medication are provided upfront; canceling early can trigger charges up to the full retail monthly price. Additional fees include a $99 administrative fee if canceling before the consult, a $199 chargeback fee, and a $150 reprocessing/reshipping fee for address errors. These terms can negate savings if circumstances change.Value score reflects the strong sticker price tempered by rigidity and fee exposure. Patients certain about continuing therapy for at least one quarter will capture the greatest value; those seeking purely month‑to‑month flexibility may not.

NewSelf lists multiple partner compounding pharmacies (e.g., Wells Pharmacy, Olympia Pharmacy, Pharmaneek, Beaker) and discloses its physician network (MD Integrations). The platform’s safety pages mirror labeled risks for semaglutide and tirzepatide and reinforce that clinical eligibility and dose are determined by independent providers. The company also states it is LegitScript certified, positioning itself as operating under heightened compliance oversight.While pharmacy transparency is a positive, the site does not present public Certificates of Analysis on product pages, and it does not specify whether partners operate as 503A or 503B facilities. Given the compounded nature of medications, quality hinges on pharmacy practices that are partially external to NewSelf’s direct control.Overall, we score quality above average for transparency and explicit safety content, with a small deduction for limited public batch‑level documentation.

Onboarding begins with a short digital intake and telehealth evaluation. NewSelf advertises in‑stock status and free overnight shipping once approved, and elsewhere indicates most orders ship within ~72 hours on business days. We view the flow as straightforward: questionnaire → provider review → pharmacy fulfillment → doorstep delivery.Strengths include clear next‑step messaging and the option (per Terms) to direct a prescription to a different pharmacy if coordinated pre‑order. Potential friction emerges post‑purchase if expectations on dose escalation or timing diverge from provider judgment or pharmacy operations.We award a strong score for simplicity and speed claims, with minor deductions for real‑world variability tied to clinical discretion and fulfillment.

NewSelf’s weight‑loss offering focuses on compounded semaglutide and compounded tirzepatide; it explicitly distances its program from brand‑name products and notes no affiliation with brand manufacturers. Safety content is extensive, and prescribing decisions rest with independent clinicians per policy. Patients seeking brand drugs through insurance will likely need alternative pathways.The program markets single‑price dosing across titration ranges, which is attractive for patients who progress beyond starting doses. Still, options appear centered on injectable compounded formulations; we did not find oral GLP‑1 offerings or adjacent metabolic therapies outlined at the same level of detail.Score reflects strong focus but narrower breadth compared with platforms that offer both brand and compounded or additional adjunct therapies.

NewSelf highlights free overnight shipping with in‑stock signaling and indicates most orders ship within 72 hours on weekdays. The Shipping & Returns policy states sterile GLP medications are cold‑shipped with medical‑grade insulation and ice packs, and asserts temperature stability up to 120°F for 3 days in case of delays.Replacement logistics require patients to report issues within 7 days; if an address was entered incorrectly, a $150 reprocessing/reshipping fee applies. There is a 3‑day waiting period from the expected delivery date before replacement processing for transit delays. These policies are standard to conservative for cold‑chain fulfillment.We score above average for speed and packaging clarity, with small deductions for restrictive windows and reship fees.

Public review patterns show quick responses to negative feedback and a predominantly positive tenor on outcomes. We also note at least one account describing difficulty reaching support or clarifying dosing expectations, prompting back‑and‑forth post‑purchase. Because clinical decisions are independent, some support issues may involve provider‑patient communication rather than platform logistics alone.NewSelf lists clear contact details and indicates 24/7 medical support in marketing. However, the existence of chargeback‑related language and fee schedules in policy documents suggests a more formal stance on billing disputes, which can feel rigid to consumers and may escalate dissatisfaction if expectations are misaligned.Score lands in the mid‑range: responsive posture overall, with isolated friction around communication and finance‑policy boundaries.

The site is modern and generally easy to navigate, with bold pricing blocks, clear action buttons, and prominent policy links. We appreciate the presence of partner and safety pages in the footer, enhancing transparency.That said, we encountered occasional placeholder text and marketing claims (e.g., “cancel anytime”) that do not fully align with the commitment terms in the policies page, which can create avoidable confusion for first‑time buyers. Tightening copy consistency across sales and policy surfaces would further strengthen trust.Net: a polished experience that would benefit from stricter alignment between marketing and legal language.